Flemington, NJ, United States of America

Ellen S Kurtz

This inventor holds 1 USPTO granted patent. Top assignees: Hoechst Aktiengesellschaft, Hoechst Roussel Pharmaceuticals. Active years: 1996.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ellen S Kurtz. Retrieved from https://idiyas.com/inventor/ellen-s-kurtz-qb5qhvou

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 1996

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Journey of Ellen S. Kurtz

Introduction: Ellen S. Kurtz, hailing from Flemington, New Jersey, has made significant contributions to the field of pharmaceuticals, particularly in the treatment of skin disorders. With one notable patent to her name, she has showcased her dedication to innovation in medicine.

Latest Patents: Ellen's most significant patent is focused on a pharmaceutical formulation for the treatment of skin disorders, specifically psoriasis. This patent describes compounds within certain formulas and their physiologically tolerable salts, highlighting their effectiveness in treating this chronic condition.

Career Highlights: Throughout her career, Ellen has worked with prominent pharmaceutical companies, such as Hoechst Aktiengesellschaft and Hoechst Roussel Pharmaceuticals. Her work has left a lasting impact on the industry, particularly in the realm of dermatological therapies.

Collaborations: Ellen has collaborated with esteemed professionals, including Robert R. Bartlett and Klaus U. Weithmann. Their combined expertise has undoubtedly contributed to the advancements in pharmaceutical innovations.

Conclusion: Ellen S. Kurtz's work exemplifies the spirit of innovation in pharmaceuticals. Her contributions to the treatment of skin disorders are commendable, emphasizing the importance of research and collaboration in enhancing healthcare outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…